Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy

Journal of Geriatric Psychiatry and Neurology

Volumn 18, Issue 1, 2005, Pages 20-24

  Orengo, Claudia A ^a,b,c   Fullerton, Laura ^a,b   Kunik, Mark E ^a,b,c,d  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Vet Affairs South Central MIRECC ^*  (United States)

^d Houston Ctr Qual Care Utiliz S   (United States)

Author keywords

Depression; Elderly; Testosterone

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NEFAZODONE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE;

ADD ON THERAPY; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HAMILTON SCALE; HUMAN; HYPOGONADISM; MALE; PRIORITY JOURNAL; PROFILE OF MOOD STATES; QUALITY OF LIFE; QUALITY OF LIFE SATISFACTION QUESTIONNAIRE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SIDE EFFECT; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL;

EID: 14644404967     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/0891988704271767     Document Type: Article

References (22)

1. National Institute of Mental Health. Depression (NIMH Pub No. 03-4972). Bethesda, Md: National Institute of Mental Health, 2003.
2. Mulsant BH, Pollock BG. Treatment resistant depression in late life. J Geriatr Psychiatry Neurol 1998; 11(4): 186-193.
3. Cole MG, Bellavance F, Mansour A. A prognosis of depression in elderly community and primary care populations: s systemic review and meta-analysis. Am J Psychiatry 1999; 156(8):1182-1189.
4. Schneider LS, Olin JT. Efficacy of acute treatment for geriatric depression. Int Psychogeriatr 1995; 7(suppl):7-25.
5. Seidman SN, Walsh BT. Testosterone and depression in aging men. Am J Geriatr Psychiatry 1999; 7:18-33.
6. Vermeulen A, Kaufman JM. Aging of the hypothalamo-pituitary-testicular axis in men. Hormone Res 1995; 43:25-28.
7. Tenover JL. Testosterone and the aging male. J Androl 1997; 18(2):103-106.
8. Barrett-Connor E, von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 1999; 84:573-577.
9. Rubin RT, Poland RE, Lesser IM. Neuroendocrine aspects of primary endogenous depression VIII: pituitary-gonadal axis activity in male patients and matched control subjects. Psychoneuroendocrinology 1979; 14(3):217-229.
10. Yesavage JA, Davidson J, Widrow L, Berger PA. Plasma testosterone levels, depression, sexuality and age. Biol Psychiatr 1985; 20:199-225.
11. Burris AS, Banks SM, Carter CS, Davidson JM, Sherins R. A long-term, prospective study of the physiologic and behavior effects of hormone replacement in untreated hypogonadal impotent men. J Androl 1992; 13(4):297-304.
12. Davidson JM, Cmargo CA, Smith ER. Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 1979; 48:955.
13. Masand PS. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001; 158(5):805-807.
14. O'Carroll R, Shapiro C, Bancroft J. Androgens, behavior and nocturnal erection in hypogonadal men - a clinical research center study. Clin Endocrinol 1985; 23:527-538.
15. Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12 month randomized controlled trial. J Clin Endo Metabol 1997; 82:1661-1667.
16. Rabkin JG, Wagner GJ, Rabkin R. Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol 1999; 19(1):19-27.
17. Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000; 57(2): 141-147.
18. Grinspoon S, Corcoran C, Stanley, T, Baaj A, Basgoz N, Klibanski A. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab 2000; 85:60-65.
19. Pope HG, Cohane GH, Kanayama G, Siegel AJ, Hudson JI. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003; 160:105-111.
20. Alexopoulos GS, Katz IR, Reynolds CF, Carpenter D, Docherty JP. The expert consensus guideline series: pharmacotherapy of depressive disorders in older patients. Postgrad Med Special Rep 2001; October:1-86.
21. Perry PJ, Yates WR, Williams RD, et al. Testosterone therapy in late-life major depression in males. J Clin Psychiatry 2002; 63(12):1096-1101.
22. Seidman SN, Rabkin JG. Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. J Affect Disord 1998; 48:157-161.